- $14.60m
- -$120.44m
- CNY412.64m
- 42
- 87
- 34
- 54
Annual income statement for 9F, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,425 | 1,256 | 747 | 562 | 413 |
Cost of Revenue | |||||
Gross Profit | 3,288 | 713 | 700 | 446 | 297 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6,940 | 3,089 | 852 | 1,177 | 659 |
Operating Profit | -2,515 | -1,833 | -104 | -615 | -246 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2,220 | -1,692 | -202 | -603 | -152 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2,046 | -2,230 | -228 | -614 | -160 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2,160 | -2,259 | -237 | -595 | -140 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2,170 | -2,259 | -235 | -595 | -140 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -237 | -191 | -19.9 | -1.25 | -0.45 |